Berking Biotechnology
Generates single-chain antibodies derived from camelids for advanced cancer therapies and for controlling diseases in salmon.
Provides antibody-based biotherapeutics aimed at clinical oncology and aquaculture health management.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A